The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials

In this study, we conducted a meta-analysis to assess the efficacy and safety of teprotumumab in treating thyroid eye disease. We searched the Cochrane Library, PubMed, and Embase databases from inception to May 25, 2022, and included all randomized controlled trials. Odds ratios (ORs) were calculat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Fei, Yao, Qiu'e, Yu, Bin, Deng, Zehui, Qiu, Jingyue, He, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427239/
https://www.ncbi.nlm.nih.gov/pubmed/37588100
http://dx.doi.org/10.1155/2023/6638089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427239/
https://www.ncbi.nlm.nih.gov/pubmed/37588100
http://dx.doi.org/10.1155/2023/6638089

Ejemplares similares